tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CPRX Stock Latest News

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
Press ReleasesCatalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
13h ago
CPRX
Catalyst Pharmaceuticals (NASDAQ:CPRX): A Growth-Oriented Value Investment Opportunity
PremiumMarket News
Catalyst Pharmaceuticals (NASDAQ:CPRX): A Growth-Oriented Value Investment Opportunity
29d ago
CPRX
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
PremiumPress Releases
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
2M ago
CPRX
Catalyst receives FDA approval for increased maximum daily dose for FIRDAPSE
PremiumThe Fly
Catalyst receives FDA approval for increased maximum daily dose for FIRDAPSE
2M ago
CPRX
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
PremiumPress Releases
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
2M ago
CPRX
Catalyst Pharmaceuticals price target raised to $26 from $24 at H.C. Wainwright
PremiumThe FlyCatalyst Pharmaceuticals price target raised to $26 from $24 at H.C. Wainwright
2M ago
CPRX
Catalyst Pharmaceutical’s Buyback: A Double-Edged Sword for Financial Health and R&D Investment?
PremiumCompany Announcements
Catalyst Pharmaceutical’s Buyback: A Double-Edged Sword for Financial Health and R&D Investment?
2M ago
CPRX
Catalyst Pharmaceuticals reports Q1 EPS 19c, consensus 17c
PremiumThe Fly
Catalyst Pharmaceuticals reports Q1 EPS 19c, consensus 17c
3M ago
CPRX
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
3M ago
CPRX
Catalyst Pharmaceutical Partners (CPRX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Catalyst Pharmaceutical Partners (CPRX) Q1 Earnings Cheat Sheet
3M ago
CPRX
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
PremiumPress Releases
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
3M ago
CPRX
Catalyst Pharmaceuticals announces support for inaugural LEMS awareness day
PremiumThe Fly
Catalyst Pharmaceuticals announces support for inaugural LEMS awareness day
4M ago
CPRX
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
PremiumPress ReleasesCatalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
4M ago
CPRX
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
PremiumPress Releases
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
4M ago
CPRX
Catalyst Pharmaceuticals management to meet with Oppenheimer
PremiumThe Fly
Catalyst Pharmaceuticals management to meet with Oppenheimer
4M ago
CPRX
Catalyst Pharmaceuticals initiated with a Buy at Citi
PremiumThe Fly
Catalyst Pharmaceuticals initiated with a Buy at Citi
4M ago
CPRX
Catalyst Pharmaceuticals management to meet with Oppenheimer
PremiumThe Fly
Catalyst Pharmaceuticals management to meet with Oppenheimer
4M ago
CPRX
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
PremiumPress Releases
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
4M ago
CPRX
Catalyst Pharmaceuticals announces commercial availability of AGAMREE
PremiumThe Fly
Catalyst Pharmaceuticals announces commercial availability of AGAMREE
4M ago
CPRX
‘Time to Hit Buy,’ Says Bank of America About These 3 Stocks
PremiumStock Analysis & Ideas‘Time to Hit Buy,’ Says Bank of America About These 3 Stocks
4M ago
CPRX
SBAC
BofA starts ‘unique aggregator’ Catalyst Pharmaceuticals with a Buy
PremiumThe Fly
BofA starts ‘unique aggregator’ Catalyst Pharmaceuticals with a Buy
5M ago
CPRX
Catalyst Pharmaceuticals initiated with a Buy at BofA
PremiumThe Fly
Catalyst Pharmaceuticals initiated with a Buy at BofA
5M ago
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >